Clinical Trial Update: Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tacrolimus and sirolimus with or without ustekinumab for prevention of acute graft-versus-host disease has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Graft vs. Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-09-10